Lupus Education Alliance Program

NCT05243875 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 274

Last updated 2025-08-03

No results posted yet for this study

Summary

Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).

Conditions

Interventions

BEHAVIORAL

LEAP Education + Navigation

COVID education involving providing information about COVID for people with SLE and CDC recommendations for testing, testing options (e.g., pharmacies, doctors' offices, at-home), treatment in the event of a positive COVID result, and current recommendations around vaccination for those with SLE; and (2) navigation, which involves individual tailoring of information about where and how to get tested, and where to get vaccinated, and when appropriate, guiding participants in scheduling testing and vaccination appointments.

BEHAVIORAL

LEAP Education

COVID education involving providing information about COVID for people with SLE and CDC recommendations for testing, testing options (e.g., pharmacies, doctors' offices, at-home), treatment in the event of a positive COVID result, and current recommendations around vaccination for those with SLE.

Sponsors & Collaborators

  • University of Alabama at Birmingham

    collaborator OTHER
  • Ochsner Health System

    collaborator OTHER
  • Louisiana State University Health Sciences Center in New Orleans

    collaborator OTHER
  • Tulane University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2025-06-15
Completion
2025-06-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05243875 on ClinicalTrials.gov